We have previously reported that human IGFBP-1, when overexpressed in mice, leads to vascular insulin sensitization; increased nitric bioavailability; reduced atherosclerosis [15]; and enhanced vascular repair [16]. The gene discussed is IGFBP1; the disease is atherosclerosis.